Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $8.52 billion. The enterprise value is $8.43 billion.
| Market Cap | 8.52B |
| Enterprise Value | 8.43B |
Important Dates
The last earnings date was Tuesday, October 29, 2024, after market close.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
Chemed has 14.93 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Current Share Class | 14.93M |
| Shares Outstanding | 14.93M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 97.16% |
| Float | 14.67M |
Valuation Ratios
The trailing PE ratio is 28.86 and the forward PE ratio is 23.54. Chemed's PEG ratio is 2.14.
| PE Ratio | 28.86 |
| Forward PE | 23.54 |
| PS Ratio | 3.62 |
| Forward PS | 3.27 |
| PB Ratio | 6.90 |
| P/TBV Ratio | 17.98 |
| P/FCF Ratio | 27.27 |
| P/OCF Ratio | 23.60 |
| PEG Ratio | 2.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.62, with an EV/FCF ratio of 26.98.
| EV / Earnings | 27.95 |
| EV / Sales | 3.55 |
| EV / EBITDA | 19.62 |
| EV / EBIT | 22.69 |
| EV / FCF | 26.98 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.85 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.47 |
| Interest Coverage | 228.96 |
Financial Efficiency
Return on equity (ROE) is 26.76% and return on invested capital (ROIC) is 18.29%.
| Return on Equity (ROE) | 26.76% |
| Return on Assets (ROA) | 13.94% |
| Return on Capital (ROIC) | 18.29% |
| Revenue Per Employee | $157,567 |
| Profits Per Employee | $20,000 |
| Employee Count | 15,087 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 136.49 |
Taxes
In the past 12 months, Chemed has paid $93.20 million in taxes.
| Income Tax | 93.20M |
| Effective Tax Rate | 23.60% |
Stock Price Statistics
The stock price has decreased by -1.52% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -1.52% |
| 50-Day Moving Average | 578.92 |
| 200-Day Moving Average | 579.99 |
| Relative Strength Index (RSI) | 52.81 |
| Average Volume (20 Days) | 113,694 |
Short Selling Information
The latest short interest is 259,077, so 1.74% of the outstanding shares have been sold short.
| Short Interest | 259,077 |
| Short Previous Month | 236,664 |
| Short % of Shares Out | 1.74% |
| Short % of Float | 1.77% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, Chemed had revenue of $2.38 billion and earned $301.73 million in profits. Earnings per share was $19.78.
| Revenue | 2.38B |
| Gross Profit | 847.80M |
| Operating Income | 371.61M |
| Pretax Income | 387.17M |
| Net Income | 301.73M |
| EBITDA | 429.86M |
| EBIT | 371.61M |
| Earnings Per Share (EPS) | $19.78 |
Balance Sheet
The company has $238.45 million in cash and $147.91 million in debt, giving a net cash position of $90.55 million or $6.07 per share.
| Cash & Cash Equivalents | 238.45M |
| Total Debt | 147.91M |
| Net Cash | 90.55M |
| Net Cash Per Share | $6.07 |
| Equity (Book Value) | 1.24B |
| Book Value Per Share | 82.78 |
| Working Capital | 225.66M |
Cash Flow
In the last 12 months, operating cash flow was $361.15 million and capital expenditures -$48.55 million, giving a free cash flow of $312.60 million.
| Operating Cash Flow | 361.15M |
| Capital Expenditures | -48.55M |
| Free Cash Flow | 312.60M |
| FCF Per Share | $20.94 |
Margins
Gross margin is 35.66%, with operating and profit margins of 15.63% and 12.69%.
| Gross Margin | 35.66% |
| Operating Margin | 15.63% |
| Pretax Margin | 16.61% |
| Profit Margin | 12.69% |
| EBITDA Margin | 18.08% |
| EBIT Margin | 15.63% |
| FCF Margin | 10.96% |
Dividends & Yields
This stock pays an annual dividend of $1.80, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | $1.80 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | 15.38% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 9.10% |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.41% |
| Earnings Yield | 3.54% |
| FCF Yield | 3.67% |
Analyst Forecast
The average price target for Chemed is $641.50, which is 12.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $641.50 |
| Price Target Difference | 12.36% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 14.03 and a Piotroski F-Score of 6.
| Altman Z-Score | 14.03 |
| Piotroski F-Score | 6 |